Empresa Pain Therapeutics, Inc. Nasdaq
Acciones
US69562K5065
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Remi Barbier
CEO | Chief Executive Officer | 64 | 01/05/98 |
Eric Schoen
DFI | Director of Finance/CFO | 55 | 01/10/18 |
James Kupiec
CTO | Chief Tech/Sci/R&D Officer | - | 04/01/21 |
Michael Zamloot
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Director/Board Member | 65 | 01/06/98 | |
Robert Cook
LAW | General Counsel | 60 | 01/10/22 |
Michael Marsman
LAW | General Counsel | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Remi Barbier
CEO | Chief Executive Officer | 64 | 01/05/98 |
Robert Gussin
BRD | Director/Board Member | 86 | 01/03/03 |
Patrick Scannon
BRD | Director/Board Member | 76 | 07/12/07 |
Director/Board Member | 92 | 01/09/98 | |
Richard Barry
BRD | Director/Board Member | 65 | 11/06/21 |
Director/Board Member | 65 | 01/06/98 | |
Claude Nicaise
BRD | Director/Board Member | 71 | 07/12 |
Robert Anderson
BRD | Director/Board Member | 58 | 07/12 |
Pierre Gravier
BRD | Director/Board Member | 39 | 07/12 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 43 245 758 | 40 141 808 ( 92,82 %) | 0 | 92,82 % |
Información de la empresa
Cassava Sciences, Inc.
6801 North Capital of Texas Highway Suite 300
78731, Austin
+512 501 2444
http://www.cassavasciences.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
-2,86 % | 102 mil M | |
+1,87 % | 96,09 mil M | |
+2,13 % | 22,28 mil M | |
-16,43 % | 21,4 mil M | |
-9,12 % | 18,14 mil M | |
-39,98 % | 17,02 mil M | |
-13,92 % | 16,09 mil M | |
+4,60 % | 13,83 mil M | |
+34,07 % | 11,97 mil M |